Genetic Basis of Mesothelioma Research Allows for Better Treatment
A new study is giving mesothelioma patients hope for better and more effective treatment options. The study, co-authored by Dr. David Sugarbaker and other physician-researchers, promotes the genetic discoveries of mesothelioma to help characterize mutational profiles in mesothelioma patients.
The research yielded great results, showing numerous clinically actionable mutations. This opens the door for more therapy and treatment options that can specifically target these mutations. There are some mutations that were found in the study which available drugs and therapies can target because they exist in other malignancies.
The study discovered 10 mutated genes and upwards of 2,500 alterations.
Research found that some of the patients with more aggressive mesothelioma show presence of a protein called PD-L1. This could prove to be a target for immunotherapy pathways. In fact, Baylor College of Medicine is already conducting a trial regarding an immunotherapy that would specifically target PD-L1 in patients who have pleural mesothelioma.
At Bailey Peavy Bailey Cowan Heckaman, it is our hope that this study helps bring to treatment options to light to help mesothelioma patients. Our mesothelioma lawyers are hopeful of what this could uncover and the various options that could be created as a result of the study’s findings.
If you developed mesothelioma, you may be able to file a lawsuit. It is important to speak with a lawyer about your possible options and determine what kind of case you have and if you can recover compensation for the damages you have sustained. Our firm is dedicated to standing by your side at all times. We offer free consultations so you can better understand your rights and options moving forward. Call us today if you or someone you love has mesothelioma and you want to see if you have a claim.